4th Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$198,708
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Torts TOR

Medical Liability Reform; Protecting Access to Care Act; Good Samaritan Health Professionals Act

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); White House Office; HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); White House Office; Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; Government Accountability Office (GAO); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Health Savings Accounts; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); SENATE; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Executive Office of the President (EOP); White House Office; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Health Issues HCR

Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Health Resources & Services Administration (HRSA); White House Office; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ)

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act; Independent Payment Advisory Board (IPAB)

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); White House Office; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

National Health Service Corps; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); SENATE; Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Insurance INS

Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Government Accountability Office (GAO)

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act; Single Accreditation

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); White House Office; Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Medical/Disease Research/Clinical Labs MED

NIH; FDA

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); SENATE; Government Accountability Office (GAO); White House Office; Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.